Topic of Research Seminar: i-Talk: AI Enabled RNA Drug Discovery
Abstract: Rabia holds a PhD in immunogenetics from McGill University and an MBA from Concordia University. She is the founder and CEO of Ladder Therapeutics, a Y-Combinator backed biotech focused on unlocking the potential of RNA biology to advance drug discovery and development.
Rabia has also held senior roles at BenevolentAI and Meta. At Meta (acquired by Chan Zuckerberg BioHub), she was pivotal in the partnership with the Intelligence Advanced Research Projects Activity (IARPA) to acquire horizon-scanning technology that used NLP to research the biomedical corpus. At BenevolentAI, she helped shape the discovery strategy, and led the Age-Related Macular Degeneration and Glioblastoma drug discovery programs and served as the interface between the technical and biological teams alongside Prof. Jackie Hunter.
Subject Field of Topic: Immunogenetics, Drug Discovery & Development
Name of Speaker: Dr. Rabia Khan
Professorial Rank of Speaker: CEO
Affiliation of Speaker: Ladder Therapeutics
Date and Venue: 29th September 2022, 1500 hrs, SINES Auditorium, NUST Islamabad Campus